The total value of the global needle-free injection systems market was USD 151.0 million in 2021, and it will rise at a growth rate of above 13.3% shortly, reaching USD 466.2 million by 2030, according to P&S Intelligence. This growth can be ascribed to the globally increasing diabetic populace, which produces high requirements for self-injection devices; growing occurrence of needlestick wounds; and fear of needles among individuals.
In the coming few years, prefilled needle-free injection devices are projected to advance with a faster CAGR, of above 14%. This can be credited to the fact that the majority of such prefilled syringes are automatic, lessening the danger of physical handling and guaranteeing a safer use. Furthermore, the U.S. is the largest revenue generator in the prefilled needle-free injectors market, because of the large diabetic and chronic illness patient base in the nation.
Moreover, such advanced systems aid patients to lessen the danger of infection or human-caused dosing mistakes. Because of the above-mentioned factors, the demand for prefilled needle-free injectors is growing throughout the globe.
The surge in needlestick wounds is expected to drive the demand for needle-free injectors. Such injectors lessen the danger of needlestick wounds and aid patients overcome needle fear. They also limit the transmission of communicable illnesses by evading cross-contamination. Needlestick wounds can reason contagious illnesses like Hepatitis-B, HIV-AIDS, and Hepatitis-C. To lessen the cases of contagious illnesses, needle-free injection systems have grown in popularity.
In recent years, the jet-based technology generated the largest revenue share in the needle-free injection systems market, and the category is also projected to maintain its dominance with a CAGR of approximately 14% in the future well. This growth can be credited to its advantages, such as less time being taken on preparing and managing the medicine, fewer needlestick wounds, ease in usage and aesthetics, and a less chance of illness spreading.
In recent years, reusable needle-free injection devices held a higher revenue share in the industry. This can be credited to the feature of refilling injectors for numerous uses. On the other hand, disposable needle-free injectors are projected to advance faster in the near future. This is because of the disposable feature of such needles that evade needlestick wounds and cross-contamination.
In the past few years, the North American needle-free injection systems market generated the highest revenue share of more than 40%, and the continent is also projected to remain dominant in the future as well. This can be credited to the existence of sophisticated healthcare infrastructure, a high level of patient knowledge, the surge in cases of chronic illnesses, and high research and development expenditure on needle-free injection technologies.
Hence, the globally increasing diabetic populace produces a high requirement for self-injection devices; a growing occurrence of needlestick wounds; and a fear of needles among individuals.
No comments:
Post a Comment